Literature DB >> 18682925

Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.

Noriko K Steiner1, Sivanesan Dakshanamurthy, Christopher J VandenBussche, Carolyn K Hurley.   

Abstract

In the human killer cell immunoglobulin-like receptors, KIR2DL2, and KIR2DL3, a triad of amino acids in the D1 domain interact to stabilize protein structure. Substitution of any one of these residues caused significant loss of cell surface expression. Although KIR2DS4 and KIR2DS5, two homologous receptors, differ for this triad, flow cytometry analysis of NK and T cell lines transfected with stimulatory KIR genes KIR2DS4 (allele *001) and KIR2DS5 (allele *002) demonstrated cell surface expression. For KIR2DS5, restoration of the triad sequence increased surface expression. Further studies of the receptor encoded by KIR2DS5*002 showed both mature and immature protein isoforms upon gel electrophoresis coupled with surface biotinylation or deglycosylation. In contrast, the KIR2DS5*001 allelic product was not expressed on the cell surface of either NK or T cells and exhibited only a single immature isoform upon gel electrophoresis. Site-directed mutagenesis demonstrated that absence of the KIR2DS5*001-encoded protein at the cell surface was imparted primarily by two amino acid polymorphisms in the D2 domain. Analysis using molecular dynamics simulations suggested that the substitution of a proline for a serine at residue 111 or the substitution of a serine for a phenylalanine at residue 164 caused destabilization of the domain structure and intracellular retention. A third polymorphism at residue 174 impacted the level of KIR2DS5 surface expression. This is the first description at a stimulatory KIR locus of the impact of specific amino acid variations on receptor maturation and the level of surface expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682925      PMCID: PMC5848465          DOI: 10.1007/s00251-008-0322-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  37 in total

Review 1.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

Review 2.  The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense.

Authors:  Arman A Bashirova; Maureen P Martin; Daniel W McVicar; Mary Carrington
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

3.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.

Authors:  M Colonna; G Borsellino; M Falco; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

4.  Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations.

Authors:  Derek Middleton; Asensio Gonzalez; Paula M Gilmore
Journal:  Hum Immunol       Date:  2007-01-05       Impact factor: 2.850

5.  Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.

Authors:  C Vilches; C M Gardiner; P Parham
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

7.  A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey.

Authors:  L D Maxwell; A Wallace; D Middleton; M D Curran
Journal:  Tissue Antigens       Date:  2002-09

8.  Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.

Authors:  Maureen P Martin; George Nelson; Jeong-Hee Lee; Fawnda Pellett; Xiaojiang Gao; Judith Wade; Michael J Wilson; John Trowsdale; Dafna Gladman; Mary Carrington
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

9.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Ann-Margaret Little; Fotini Partheniou; Peter Parham
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

10.  Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.

Authors:  Galit Alter; Maureen P Martin; Nickolas Teigen; William H Carr; Todd J Suscovich; Arne Schneidewind; Hendrik Streeck; Michael Waring; Angela Meier; Christian Brander; Jeffrey D Lifson; Todd M Allen; Mary Carrington; Marcus Altfeld
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

View more
  15 in total

1.  DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells.

Authors:  Tiernan J Mulrooney; Phillip E Posch; Carolyn Katovich Hurley
Journal:  J Leukoc Biol       Date:  2013-05-28       Impact factor: 4.962

2.  The extracellular domain of Notch2 increases its cell-surface abundance and ligand responsiveness during kidney development.

Authors:  Zhenyi Liu; Shuang Chen; Scott Boyle; Yu Zhu; Andrew Zhang; David R Piwnica-Worms; Ma Xenia G Ilagan; Raphael Kopan
Journal:  Dev Cell       Date:  2013-06-24       Impact factor: 12.270

3.  A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs.

Authors:  K Czaja; A-S Borer; L Schmied; G Terszowski; M Stern; A Gonzalez
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

4.  Molecular determinant-based typing of KIR alleles and KIR ligands.

Authors:  Rafijul Bari; Matthias Leung; Victoria E Turner; Christy Embrey; Barbara Rooney; Martha Holladay; Wing Leung
Journal:  Clin Immunol       Date:  2011-01-15       Impact factor: 3.969

5.  KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.

Authors:  Tiernan J Mulrooney; Aaron C Zhang; Yehuda Goldgur; Jeanette E Boudreau; Katharine C Hsu
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

6.  Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.

Authors:  Sabrina B Taner; Marcelo J Pando; Allison Roberts; Jennifer Schellekens; Steven G E Marsh; Karl-Johan Malmberg; Peter Parham; Frances M Brodsky
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

7.  Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.

Authors:  Rafijul Bari; Piya Rujkijyanont; Erin Sullivan; Guolian Kang; Victoria Turner; Kwan Gan; Wing Leung
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

8.  Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.

Authors:  Midrar AlHossiny; Linlin Luo; William R Frazier; Noriko Steiner; Yuriy Gusev; Bhaskar Kallakury; Eric Glasgow; Karen Creswell; Subha Madhavan; Rakesh Kumar; Geeta Upadhyay
Journal:  Cancer Res       Date:  2016-04-11       Impact factor: 12.701

9.  Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245.

Authors:  Rafijul Bari; Teresa Bell; Wai-Hang Leung; Queenie P Vong; Wing Keung Chan; Neha Das Gupta; Martha Holladay; Barbara Rooney; Wing Leung
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

10.  Allelic variation of killer cell immunoglobulin-like receptor 2DS5 impacts glycosylation altering cell surface expression levels.

Authors:  Noriko K Steiner; Sivanesan Dakshanamurthy; Nicholas Nguyen; Carolyn Katovich Hurley
Journal:  Hum Immunol       Date:  2013-11-20       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.